本文来源:https://mp.weixin.qq.com/s/WXvZFREEWYQFVZd7Cm1_vg
若有版权问题,请来信告知:13951431913#139.com 或在右方提交评论。
8 月数码圈内曝出华为 WATCH D3 全套爆料信息,这款主打医用级血压监测的穿戴设备外观迎来大幅调整。

关于华为下一代专业健康手表 WATCH D3,完整的信息已经流出来了,外观上做了比较大的改动,前代 WATCH D2 饱受诟病的医用仪器厚重外观难题得到优化,专业监测能力与日常穿搭颜值得以兼顾,新机新增两款低饱和度商务配色,弱化医疗设备视觉感。
华为穿戴分为两条清晰机型线:WATCH D 系列主打二类医械认证连续血压监测,GT 系列侧重轻薄运动与长电池续航。上代 WATCH D2 搭载微型气泵 + 内置气囊硬件,但方正厚重的机身外观劝退大量普通使用者,日常佩戴辨识度过高,观感突兀。
WATCH D3在机身轮廓维度做了重新打磨的处理,医疗感被弱化掉,并且增加了经典黑和商务金这两种低饱和配色,所以它跟休闲还有正装的搭配都不会浮现违和的情况,核心气囊硬件还是保留着的,它可以开展全天候24小时的动态血压追踪,这个就是它的核心竞争力。
气囊示波监测思路的工艺壁垒是比较高的,微型气泵加上内置气囊的研发难度,比起普通光电智能手表要超出很多,D系列用的是跟医用台式血压计同一个来源的示波测量法,就是靠气囊去采集血压波形,而不是光学估算,数值跟专业设备之间的误差是小的,具备临床参考这个维度的价值。
在全球消费电子这个领域当中,可以把气囊硬件做到规模化量产的厂商,数量是很少的,竞品都存在局限:Apple Watch只可以筛查高血压风险,精准血压测量这个东西还在FDA审批当中,没有明确的落地时间;三星手表需要使用者频繁地去做手动校准,并且它还有地区锁的难题。
单个硬件是容易模仿的,不过多年的临床算法和全流程健康生态,在短期内是难以被复刻的,这就是华为D系列长期差异化核心壁垒所在的地方。
供应链那边有爆料说新机的电池续航和健康能力得到了升级:WATCH D3在延续气囊测压硬件的同时,健康监测算法也做了升级,并且新增加了血糖风险评估和冠心病联合筛查,电池续航被提高到了7到10天;定价维度预计会有小幅度的上调。
网上传的售价是2699到2999元这个范围,在这个价位段里面,只有这一款是具备二类医械认证并且兼容全天动态血压记录的,拿它跟专业便携血压监测仪去比较的话,这个定价算是比较亲民的。
受气囊硬件结构限制,该机存在两处固有短板:第一,内置的气囊和气泵结构,导致整机的厚度和重量都偏大,戴久了会有一种坠手的感觉;第二,医用示波测压对坐姿和手臂角度是有硬性要求的,走路或者办公的途中是没办法一键就测量的,在使用上是有情形限制的。
选购指南维度,合适入手人群:高血压患者、中老年长辈、居家 24 小时血压记录需要人群、需要复诊追踪健康的商务使用者;
不建议入手的情况是:只是做日常简单的运动记录,对轻薄机身有追求,没有专业血压监测这种刚需的使用者,同品牌的GT系列会更加贴合他们的需要。
外观配色、新增健康能力、预估售价均来自数码博主爆料;气囊示波测压、二类医疗器械认证为华为 D 系列全系官方硬件规格,华为这边暂时还没有放出WATCH D3的官方预热,机型最终的外观、能力、售价和发布时间,都要以官方发布会为准。
有选购健康手表需要、家中有高血压长辈的读者可收藏本文,清晰区分 D、GT 两大系列定位,无需翻阅零散爆料比较。
Source: https://mp.weixin.qq.com/s/WXvZFREEWYQFVZd7Cm1_vg If you have copyright issues, please contact us at 13951431913#139.com or leave a comment below.
In early August, a new leak revealed comprehensive details about the Huawei WATCH D3, the latest wearable device specializing in medical-grade blood pressure monitoring. The leak highlights significant aesthetic improvements over the previous model.
The leak provides a complete overview of the next-generation Huawei WATCH D3, showcasing a major redesign from the previous model. The WATCH D2 was criticized for its bulky, instrument-like appearance, which limited its appeal for everyday wear. The new D3 addresses this by incorporating a more streamlined, fashionable design that balances professional monitoring capabilities with style. It introduces two understated, business-friendly color variants to minimize the perception of a medical device.
Huawei's smartwatch lineup is clearly segmented: the WATCH D series is dedicated to continuous blood pressure monitoring with Class II medical device certification, while the GT series focuses on lightweight, sports-oriented features and long battery life. The D2 suffered from poor adoption due to its boxy, heavy profile, which made it too conspicuous for daily use.
The D3 undergoes a subtle transformation in shape, reducing the medical "clunkiness" and introducing two new colors: Classic Black and Business Gold. These choices make the watch more versatile, allowing it to complement both casual and formal attire without looking out of place. The core inflatable cuff technology remains intact, allowing for 24-hour continuous tracking — the key selling point of the series.
The technology behind the D series — using a micro air pump and an integrated cuff — is highly complex and difficult to replicate. Unlike consumer-grade smartwatches that use optical sensors to estimate blood pressure, the D3 employs the oscillometric method used by professional medical gauges. This ensures that the readings are accurate and clinically reliable, with minimal deviation from a standard cuff.
Currently, very few consumer electronics companies have succeeded in mass-producing this level of hardware. For instance, the Apple Watch can only screen for hypertension risks and hasn't yet received FDA approval for precise cuff-free monitoring, and Samsung's device requires frequent calibration and has regional restrictions.
While the hardware concept might be copied, the years of clinical research, algorithm tuning, and ecosystem integration required make it nearly impossible for competitors to replicate Huawei's position in the short term. This establishes a significant long-term advantage for the D series.
The leak also suggests improvements in battery life and health monitoring features. The D3 is expected to offer up to 7–10 days of battery life while enhancing its suite of features to include not only blood pressure but also glucose risk estimation and coronary artery disease screening.
The rumored price range is between 2699 and 2999 CNY (roughly $370–420 USD). This is competitive for a device with this level of medical certification and the ability to monitor continuous pressure trends — a feature that portable medical monitors often lack or charge a premium for.
However, the D3 is not without its flaws. Because of the internal pump and cuff mechanism, it is noticeably thicker and heavier than a standard wristwatch — something users might find uncomfortable during prolonged wear. Additionally, accurate readings require the user to sit still with their arm in a specific position, which limits the ability to take instant measurements while walking or working.
Based on this, the ideal buyer would be someone requiring precise blood pressure tracking — such as a hypertensive patient, a senior citizen, or a business traveler needing to record data for a doctor’s visit. Conversely, if one is only interested in basic step counting or a lightweight fashion accessory, the GT series would be a better fit.
The information regarding design, color, price, and features comes from industry insiders via tech bloggers; however, all specifications are preliminary and subject to change. The final release will be confirmed at the official launch event.
If you or a loved one has a need for professional-level blood pressure monitoring, this model is worth keeping an eye on. Be sure to distinguish between the D (medical) and GT (sports/lifestyle) series when shopping.
Readers looking to purchase a health watch or with elderly family members suffering from high blood pressure can save this article. It clearly distinguishes the positioning of the D and GT series, eliminating the need to browse scattered leak comparisons.